Financing the efficient delivery of medical services while reducing costs for consumers as well as health care providers is among the most challenging domestic policy problems many countries face. RAND addresses health economics issues through innovative, high-profile research in an effort to improve the efficiency of health care organizations, reduce costs for providers and consumers, and improve financing in health care markets.
Research conducted by:
Featured at RAND
In its second term, the Obama Administration can restrain further health care spending growth—without compromising quality—by employing four broad strategies: fostering efficient and accountable providers, engaging and empowering consumers, promoting population health, and facilitating high-value innovation.
The ACA's goal of expanding access to health coverage has implications for health care costs at many levels: how it will affect individual decisions to obtain insurance, employer decisions about offering coverage, and government spending.
Journal Articles (174)
Although the data presented in this chapter focus on the direct medical costs of Interstitial cystitis (IC), patients are equally, if not more, affected by loss of work opportunities, effects on relationships, and overall diminished quality of life.
Kidney cancer, the third most common urologic malignancy and the seventh most common cancer overall, was diagnosed in an estimated 35,000 Americans in 2005, and nearly 13,000 died from it.
The economic impact of inpatient treatment for pediatric vesicoureteral reflux is considerable.
The burden of disease due to erectile dysfunction in the United States will increase with the aging of the male population.
The costs of treating bladder cancer increased steadily during a 6-year period despite a decrease in inpatient care.
Clinicians find it difficult to know which drugs are covered for their Medicare patients because formularies vary widely among Medicare Part D plans
Infertile males generally seek infertility care outside of traditional reimbursement patterns.
Increasing trends in the incidence of and costs associated with kidney cancer have been apparent for more than 10 years.
Spending in the US for the diagnosis and management of prostatitis, exclusive of pharmaceutical spending, appears to be increasing with time.
Prescription drugs are instrumental to managing and preventing chronic disease.
The introduction of Medicare Part D has generated interest in the cost of providing drug coverage to the elderly.
The authors ascertained the health care costs of androgen deprivation therapy and related skeletal events.
Today the United States may be on the cusp of changing from a cost-unconscious health care system to one that seeks value.
The authors evaluated medical utilization and economic burden of self-reported Parkinson's disease (PD) on patients and society.
Estimate the general medical costs of individuals who received behavioral health care.
Reliable predictions about long-term trends will require information on any health benefits associated with increases in diagnosis and treatment.
Little is known about the persistence of health care costs in children.
A pilot study in the field of developing quality indicators for research programming. The purpose of this document is to report on the approach, results, conclusions and recommendations arising from an evaluation of DoelmatigheidsOnderzoek (DO) projects funded by ZonMw, the Netherlands Organisation for Health Research and Development.
Foreign-born adults in Los Angeles County, California, constituted 45 percent of the county's population ages 18-64 but accounted for 33 percent of health spending in 2000. The foreign-born (especially the undocumented) use disproportionately fewer medical services and contribute less to health care costs in relation to their population share, likely because of their better relative health and lack of health insurance.
Although cataract surgery has been demonstrated to be cost-effective, 5% to 20% of patients do not benefit functionally from the procedure.